NPPB and hydrops fetalis: The ETHIC‐AHF study also involved patients with acute but stable systolic HF within 24–48 h after admission, it showed that adding ivabradine not only helps more patients achieve the target HR but also improved the LVEF and decreased the BNP after 4 months of follow‐up.7